• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Hematology

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

bySimon PanandAlex Chan
April 28, 2025
in Hematology, Infectious Disease, Rheumatology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The risk of bloodstream infections (BSIs) in individuals with indwelling peripheral intravenous catheters (PIVCs) is significantly increased after 3 days of dwell time. 

Evidence Rating Level: 2 (Good)

Study Rundown: PIVCs are common among hospitalized patients, with frequently reported adverse events associated with PIVCs being phlebitis and hematoma. Thus far, there have been limited attempts to characterize the association between BSIs and PIVCs. Indeed, the impact of dwell time on the risk of BSIs in patients with PIVCs has not been well characterized. This cohort study therefore sought to investigate the association between dwell time and the risk of BSIs in patients with PIVCs.

371,061 PIVCs were included from Geneva University Hospitals (HUG) in Switzerland. The primary outcome of interest was BSI with PIVC as defined by the European Centre for Disease Prevention and Control. 38% of patients had a dwell time of 1 to 2 days, 32% of patients had a dwell time of 3 to 4 days, and 30% had a dwell time greater than 4 days. A significantly increased risk of BSI with PIVCs was observed after 3 days of dwell time and remained increased for every day onwards. The highest number of BSI with PIVCs occurred when PIVCs were removed after 5 days. 

Overall, this study found that among patients with PIVCs, the risk of BSIs was significantly increased after 3 days of dwell time. 

Click to read the study in JAMA Network

RELATED REPORTS

Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial

Ciprofloxacin is non-inferior to aminoglycoside-ciprofloxacin for bubonic plague treatment

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

Relevant Reading: Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters

In-Depth [prospective cohort study]: More than half of hospitalized patients will have at least 1 PIVC in situ. Complications associated with PIVC that are often reported include phlebitis and hematoma. BSIs are an important, yet underestimated complication of PIVC associated with increased mortality. However, the impact of dwell time on the risk of BSIs in patients with PIVCs has not been well characterized. Indeed, there remains conflicting evidence surrounding the optimal replacement strategy of PIVCs to minimize BSIs. This cohort study therefore sought to investigate the association between dwell time and the risk of BSIs in patients with PIVCs.

371,061 pediatric and hospitalized patients with at least 1 PIVC between January 2016 and February 2020 (median patient age, 63 years [IQR, 41-79 years]; 51% female) were included from Geneva University Hospitals (HUG) in Switzerland. The primary outcome of interest was BSI with PIVC as defined by the European Centre for Disease Prevention and Control. Per patient stay, the mean (SD) number of PIVCs was 1.7 (1.6). 38% of patients had a dwell time of 1 to 2 days, 32% of patients had a dwell time of 3 to 4 days, and 30% had a dwell time greater than 4 days. In total, 61 BSIs were observed throughout the study period with the highest number of BSIs with PIVCs occuring when PIVCs were removed after 5 days. A significantly increased risk of BSI with PIVCs was observed after 3 days of dwell time versus less than 3 days (adjusted OR [AOR], 13.55; 95% CI, 5.44-34.00; P < .001), and remained increased for every day after (after 4 days versus less than 4, AOR, 8.53 [95% CI, 4.47-16.28]; after 5 days versus less than 5, AOR, 5.38 [95% CI, 3.23-8.96]; after 6 days versus less than 6, AOR, 7.63 [95% CI, 4.57-12.74; P < .001]).

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: antibioticscritical careinfectious diseaseinternal medicine
Previous Post

Motivational interviewing not effective in reducing rehospitalisation and improving patient activation among patients with respiratory failure

Next Post

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

RelatedReports

Pulmonology

Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial

September 11, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
All Specialties

Ciprofloxacin is non-inferior to aminoglycoside-ciprofloxacin for bubonic plague treatment

August 28, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025
Few high school students, young adults get HIV testing
Weekly Rewinds

2 Minute Medicine Rewind August 18, 2025

August 24, 2025
Next Post
Significant reduction in prostate screening rates after revised guidelines

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

High risk of complications, but low mortality among children with MRSA bacteremia

Hospital-onset antimicrobial resistance increased during COVID-19 pandemic

Midlife diabetes associated with cognitive decline

Military sexual trauma may increase risk of suicide attempts and drug overdoses in veterans

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Effectiveness and user experiences of a valgus brace in patients with knee osteoarthritis: A mixed-method randomised controlled trial
  • Artificial intelligence accelerates drug discovery and reduces animal testing
  • Effects of s-ketamine and midazolam on respiratory variability: A randomized controlled pilot trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.